Citadel Advisors’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-165,650
| Closed | -$12.5M | – | 7195 |
|
|
2022
Q2 | $12.5M | Sell |
165,650
-661,192
| -80% | -$49.8M | ﹤0.01% | 1121 |
|
|
2022
Q1 | $22.2M | Buy |
826,842
+180,616
| +28% | +$4.85M | ﹤0.01% | 846 |
|
|
2021
Q4 | $30.8M | Buy |
646,226
+404,278
| +167% | +$19.3M | 0.01% | 700 |
|
|
2021
Q3 | $16.1M | Buy |
241,948
+234,856
| +3,312% | +$15.6M | ﹤0.01% | 1062 |
|
|
2021
Q2 | $554K | Sell |
7,092
-96,894
| -93% | -$7.57M | ﹤0.01% | 4625 |
|
|
2021
Q1 | $9.84M | Buy |
103,986
+97,652
| +1,542% | +$9.24M | ﹤0.01% | 1445 |
|
|
2020
Q4 | $772K | Sell |
6,334
-96,388
| -94% | -$11.7M | ﹤0.01% | 3498 |
|
|
2020
Q3 | $8.97M | Buy |
102,722
+51,481
| +100% | +$4.5M | ﹤0.01% | 1164 |
|
|
2020
Q2 | $3.31M | Buy |
51,241
+39,328
| +330% | +$2.54M | ﹤0.01% | 1814 |
|
|
2020
Q1 | $532K | Buy |
+11,913
| New | +$532K | ﹤0.01% | 3352 |
|
|
2019
Q3 | – | Sell |
-45,541
| Closed | -$1.85M | – | 5295 |
|
|
2019
Q2 | $1.85M | Buy |
+45,541
| New | +$1.85M | ﹤0.01% | 2468 |
|